MBIO Insider Trading
Insider Ownership Percentage: 4.00%
Insider Buying (Last 12 Months): $237.12
Insider Selling (Last 12 Months): $240.92
Mustang Bio Share Price & Price History
Current Price: $1.01
Price Change: ▲ Price Increase of +0.0201 (2.03%)
As of 02/24/2026 05:00 PM ET
Mustang Bio Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/30/2025 | Adam J Chill | Director | Sell | 4 | $0.95 | $3.80 | 375 |  |
| 12/30/2025 | David Jin | Director | Buy | 247 | $0.96 | $237.12 | 286 | |
| 12/30/2025 | Neil Herskowitz | Director | Sell | 247 | $0.96 | $237.12 | 145 | |
| 3/18/2023 | Manuel Litchman | Director | Buy | 6 | $555.00 | $3,330.00 | 1,377 | |
Mustang Bio Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/13/2026 | Kestra Advisory Services LLC | 111,042 | $0.11M | 0.0% | +68.0% | 1.521% |  |
| 2/12/2026 | DRW Securities LLC | 73,936 | $73K | 0.0% | N/A | 1.013% | |
| 5/28/2025 | Anson Funds Management LP | 45,716 | $57K | 0.0% | N/A | 1.044% | |
| 5/14/2025 | Anson Funds Management LP | 45,716 | $57K | 0.0% | N/A | 1.383% | |
| 2/12/2025 | Geode Capital Management LLC | 284,437 | $50K | 0.0% | +15.9% | 29.629% | |
| 8/8/2024 | Thoroughbred Financial Services LLC | 53,000 | $25K | 0.0% | N/A | 0.423% | |
| 8/6/2024 | Koss Olinger Consulting LLC | 98,366 | $47K | 0.0% | N/A | 0.786% | |
| 5/20/2024 | Virtu Financial LLC | 30,176 | $31K | 0.0% | N/A | 0.290% | |
| 2/13/2024 | Armistice Capital LLC | 435,764 | $0.59M | 0.0% | N/A | 4.726% | |
| 7/31/2023 | Koss Olinger Consulting LLC | 100,000 | $0.62M | 0.1% | N/A | 1.225% | |
| 7/27/2023 | B. Riley Wealth Advisors Inc. | 10,240 | $64K | 0.0% | N/A | 0.125% | |
| 5/10/2023 | Oppenheimer & Co. Inc. | 91,982 | $34K | 0.0% | -11.6% | 1.251% | |
| 5/1/2023 | Arete Wealth Advisors LLC | 15,538 | $5.70B | 0.0% | N/A | 0.211% | |
| 2/8/2023 | Oppenheimer & Co. Inc. | 104,077 | $41K | 0.0% | -14.0% | 0.098% | |
| 11/18/2022 | Spotlight Asset Group Inc. | 305,312 | $0.14M | 0.1% | N/A | 0.288% | |
| 11/14/2022 | Ergoteles LLC | 288,934 | $0.14M | 0.0% | -14.4% | 0.272% | |
| 11/14/2022 | Oppenheimer & Co. Inc. | 120,980 | $57K | 0.0% | +168.9% | 0.114% | |
| 11/7/2022 | Western Wealth Management LLC | 90,000 | $42K | 0.0% | N/A | 0.085% | |
| 8/15/2022 | Laurion Capital Management LP | 1,445,600 | $0.85M | 0.0% | N/A | 1.403% | |
| 8/12/2022 | Ikarian Capital LLC | 246,824 | $0.15M | 0.0% | -54.9% | 0.240% | |
| 5/11/2022 | GSA Capital Partners LLP | 1,216,445 | $1.23M | 0.2% | -7.7% | 1.213% | |
| 5/2/2022 | National Asset Management Inc. | 310,926 | $0.32M | 0.0% | +16.1% | 0.310% | |
| 2/15/2022 | Sassicaia Capital Advisers LLC | 15,500 | $26K | 0.2% | N/A | 0.017% | |
| 2/14/2022 | GSA Capital Partners LLP | 1,318,400 | $2.19M | 0.3% | +135.3% | 1.411% | |
| 2/9/2022 | Dimensional Fund Advisors LP | 927,589 | $1.54M | 0.0% | -12.3% | 0.993% | |
| 2/8/2022 | ProShare Advisors LLC | 28,907 | $48K | 0.0% | N/A | 0.031% | |
| 2/8/2022 | Northern Trust Corp | 617,969 | $1.03M | 0.0% | -8.5% | 0.661% | |
| 2/7/2022 | SG Americas Securities LLC | 19,958 | $33K | 0.0% | -52.1% | 0.021% | |
| 2/7/2022 | Arete Wealth Advisors LLC | 15,538 | $26K | 0.0% | N/A | 0.017% | |
| 2/4/2022 | Envestnet Asset Management Inc. | 42,311 | $70K | 0.0% | +139.3% | 0.045% | |
| 2/3/2022 | Los Angeles Capital Management LLC | 136,876 | $0.23M | 0.0% | +24.7% | 0.147% | |
| 2/2/2022 | PVG Asset Management Corp | 14,870 | $25K | 0.1% | N/A | 0.016% | |
| 1/28/2022 | National Asset Management Inc. | 267,836 | $0.45M | 0.0% | +5.7% | 0.287% | |
| 11/16/2021 | National Asset Management Inc. | 253,275 | $0.68M | 0.0% | +7.2% | 0.277% | |
| 11/16/2021 | Two Sigma Advisers LP | 1,235,200 | $3.32M | 0.0% | -13.7% | 1.351% | |
| 11/16/2021 | Two Sigma Investments LP | 948,415 | $2.55M | 0.0% | -29.3% | 1.038% | |
| 11/15/2021 | Dimensional Fund Advisors LP | 1,058,259 | $2.85M | 0.0% | -28.3% | 1.158% | |
| 11/12/2021 | Renaissance Technologies LLC | 487,400 | $1.31M | 0.0% | +3,106.6% | 0.533% | |
| 11/12/2021 | Geode Capital Management LLC | 1,346,126 | $3.62M | 0.0% | +11.3% | 1.473% | |
| 11/10/2021 | Goldman Sachs Group Inc. | 248,606 | $0.67M | 0.0% | +210.0% | 0.272% | |
Data available starting January 2016
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
Read More on Mustang Bio
Volume
30,333 shs
Average Volume
266,340 shs
Market Capitalization
$7.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.14
Who are the company insiders with the largest holdings of Mustang Bio?
Who are the major institutional investors of Mustang Bio?
Which institutional investors are buying Mustang Bio stock?
Within the previous quarter, MBIO stock was bought by institutional investors including:
- DRW Securities LLC
- Kestra Advisory Services LLC
